News
FDA Fully Approves Moderna’s COVID Vaccine for Some Young Kids
The move makes Moderna’s vaccine, called Spikevax, the first COVID shot for kids in the U.S. to be fully approved, rather than used under emergency authorization, STAT News reported. The vaccine can now to be given to children ages 6 months through 11 years,
Moderna Receives Full U.S. FDA Approval for COVID-19 Vaccine, Spikevax, in Children Aged 6 Months Through 11 Years at Increased Risk for COVID-19 Disease
Spikevax is now approved for all adults aged 65 years and older, and individuals aged 6 months through 64 years at increased risk for COVID-19 disease
Moderna COVID vaccine gets FDA green light for kids 6 months to 11 years
The U.S. Food and Drug Administration has granted full approval for Moderna's MRNA.O COVID-19 vaccine, Spikevax, in children aged 6 months through 11 years who are at an increased risk of the disease, the company said on Thursday.
Researchers from Tel Aviv University and the Israel Institute for Biological Research in Ness Ziona have used the platform ...
Compared to the standard shot, the mRNA vaccine had an overall vaccine efficacy that was 26.6 percent higher, and 27.4 ...
A Pennsylvania Representative is looking to ban testing mRNA vaccines on domestic animals. Representative Jacob Banta ...
The elephant vaccine closely resembles other mRNA vaccines made for humans. mRNA packed in lipid nanoparticles carries ...
In this episode presented by Eclipsebio, BioSpace's head of insights Lori Ellis discusses mRNA and srRNA with Andy Geall of ...
If we don’t invest in technologies like mRNA vaccines for pandemic influenza now, once a virus starts going human-to-human, ...
11d
The phase three study data clears the path forward for Moderna’s combination jab targeting Covid-19 and influenza.
The mRNA drug developer said it will begin discussing approval with the FDA, which has adopted stricter vaccine review ...
Moderna's mRNA flu vaccine showed 26.6% better efficacy than a standard flu shot in adults 50 and older during a global Phase ...
Zacks Investment Research on MSN8h
MRNA Stock Up on Full FDA Nod for COVID-19 Jab in Pediatric PatientsModerna MRNA announced that the FDA has approved its supplemental biologics license application seeking approval for COVID-19 vaccine, Spikevax, for use in children aged six months to 11 years, who ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback